LONDON BROKER RATINGS: Exane raises Rentokil; RBC cuts Centrica

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

----------

FTSE 100

----------

Exane raises Rentokil Initial to 'outperform' (neutral) - price target 620 (475) pence

----------

RBC cuts Centrica to 'sector perform' (outperform) - price target 145 (140) pence

----------

Deutsche Bank raises Admiral price target to 2,600 (2,520) pence - 'hold'

----------

Deutsche Bank raises Aviva price target to 515 (490) pence - 'hold'

----------

Redburn reinitiates Spirax-Sarco with 'neutral' - price target 9,895 pence

----------

RBC raises Beazley price target to 975 (775) pence - 'outperform'

----------

Jefferies raises Persimmon price target to 1,714 (1,706) pence - 'buy'

----------

Jefferies raises Aviva price target to 525 (490) pence - 'buy'

----------

Exane BNP raises Reckitt to 'outperform' (neutral) - price target 5,300 (5,600) pence

----------

Jefferies cuts Reckitt price target to 4,000 (4,600) pence - 'underperform'

----------

FTSE 250

----------

Jefferies raises Vistry price target to 1,128 (1,023) pence - 'hold'

----------

Bank of America raises Aston Martin to 'buy' (neutral) - price target 250 (230) pence

----------

Jefferies cuts Aston Martin price target to 275 (330) pence - 'buy'

----------

RBC raises Hiscox price target to 1,275 (1,075) pence - 'sector perform'

----------

RBC cuts Pets at Home price target to 245 (260) pence - 'underperform'

----------

Barclays raises Bodycote price target to 720 (650) pence - 'equal weight'

----------

investec starts Telecom plus with 'buy' - price target 2197 pence

----------

Deutsche Bank raises Just Group price target to 105 (90) pence - 'hold'

----------

Numis cuts Bytes Technology to 'hold' (add) - price target 585 (575) pence

----------

SMALL CAP

----------

Deutsche Bank raises CRH price target to 7,340 (6,012) EUR - 'buy'

----------

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.